Financing, Equity Capital Markets

Lexicon Pharmaceuticals, Inc.

05/23
|
$134.3 Million
Lexicon
Piper Sandler served as bookrunner for Lexicon Pharmaceuticals, Inc. on a confidentially marketed follow-on offering and PIPE offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma